Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBC) Cost of Revenue (2023 - 2025)

Historic Cost of Revenue for Medical Group Holdings (SBC) over the last 3 years, with Q3 2025 value amounting to $12.7 million.

  • Medical Group Holdings' Cost of Revenue rose 2941.31% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $46.2 million, marking a year-over-year decrease of 2000.96%. This contributed to the annual value of $49.4 million for FY2024, which is 1222.18% down from last year.
  • According to the latest figures from Q3 2025, Medical Group Holdings' Cost of Revenue is $12.7 million, which was up 2941.31% from $13.3 million recorded in Q2 2025.
  • Medical Group Holdings' 5-year Cost of Revenue high stood at $19.0 million for Q4 2023, and its period low was $9.6 million during Q1 2025.
  • In the last 3 years, Medical Group Holdings' Cost of Revenue had a median value of $13.3 million in 2025 and averaged $13.1 million.
  • In the last 5 years, Medical Group Holdings' Cost of Revenue tumbled by 4443.16% in 2024 and then soared by 2941.31% in 2025.
  • Over the past 3 years, Medical Group Holdings' Cost of Revenue (Quarter) stood at $19.0 million in 2023, then tumbled by 44.43% to $10.5 million in 2024, then grew by 20.8% to $12.7 million in 2025.
  • Its last three reported values are $12.7 million in Q3 2025, $13.3 million for Q2 2025, and $9.6 million during Q1 2025.